Evidence map›Paper›PMID 36479999›Full record

ArticleBasic & clinical pharmacology & toxicology2023

Sodium bicarbonate reverts electrophysiologic cardiotoxicity of ropivacaine faster than lipid emulsions in a porcine model.

Matilde Zaballos, Ignacio Fernández, Arturo Melone, Lucía Rodríguez, Olalla Varela, Sergio García, Oscar Quintela, Elena Vazquez, María José Anadón, Jesús Almendral

Open access · hybridAbstract read
In one paragraph

Article in Basic & clinical pharmacology & toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Matilde ZaballosDepartment of Toxicology, Faculty of Medicine, Complutense University, Madrid, Spain.ORCID https://orcid.org/0000-0002-1398-8965
Ignacio FernándezDepartment of Anaesthesiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Arturo MeloneDepartment of Anaesthesiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Lucía RodríguezDepartment of Anaesthesiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Olalla VarelaDepartment of Anaesthesiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Sergio GarcíaDepartment of Anaesthesiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Oscar QuintelaDepartment of Toxicology, Faculty of Medicine, Complutense University, Madrid, Spain.
Elena VazquezHospital General Universitario Gregorio Marañón, Madrid, Spain.
María José AnadónFaculty of Medicine, Complutense University, Madrid, Spain.
Jesús AlmendralDirector of the Electrophysiology Laboratory and Arrhythmia Unit, Hospital Monteprincipe, Grupo HM Hospitales, University CEU-San Pablo, Madrid, Spain.
Hospital General Universitario Gregorio Marañón · ESUniversidad Complutense de Madrid · ESUniversidad San Pablo CEU · ES

Funding

Fondo Europeo de Desarrollo Regional PI15/00695Ministry of Economy, Industry, and Competitiveness of Spain
6 · The paper itself

Abstract

Ropivacaine has been described as a safer local anaesthetic (LA); however, serious cardiotoxic accidents have been reported. Intravenous-lipid-emulsion (ILE) therapy during LA intoxication seems to act as an antidote. Sodium bicarbonate is the standard treatment for sodium channel blocker drug toxicity. We compared both antidotes on the reversion of electrophysiologic toxicity induced by ropivacaine. Ropivacaine 5 mg kg

Indexed as

CardiotoxicitySodium BicarbonateAnesthetics, LocalAnimalsAntidotesFat Emulsions, IntravenousHeart RateLipidsRopivacaineSwineAnesthetics, LocalAntidotesFat Emulsions, IntravenousLipidsRopivacaineSodium Bicarbonatecardiotoxicitylipid emulsionsropivacainesodium bicarbonate

Identifiers

PMID36479999
PMCPMC10107242
OpenAlexW4311590136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.